LAG3 and neoplasm: LAG 3 [30] and BTLA4 [31] have been involved in the immunosuppression in Hodgkin lymphoma and synergistic effects in the restitution of the exhausted immune response between anti-PD1 and anti-LAG3 have been shown in several tumor systems [32, 33].